Tilray Brands (TLR2) Stock Overview
A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
TLR2 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Tilray Brands, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$4.07 |
| 52 Week High | US$19.10 |
| 52 Week Low | US$3.16 |
| Beta | 1.87 |
| 1 Month Change | -12.30% |
| 3 Month Change | -32.14% |
| 1 Year Change | 27.43% |
| 3 Year Change | -72.25% |
| 5 Year Change | n/a |
| Change since IPO | -84.81% |
Recent News & Updates
Recent updates
Shareholder Returns
| TLR2 | AT Pharmaceuticals | AT Market | |
|---|---|---|---|
| 7D | -4.6% | -0.2% | 2.0% |
| 1Y | 27.4% | 11.2% | 37.7% |
Return vs Industry: TLR2 exceeded the Austrian Pharmaceuticals industry which returned 11.2% over the past year.
Return vs Market: TLR2 underperformed the Austrian Market which returned 37.7% over the past year.
Price Volatility
| TLR2 volatility | |
|---|---|
| TLR2 Average Weekly Movement | 9.3% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in AT Market | 7.1% |
| 10% least volatile stocks in AT Market | 2.7% |
Stable Share Price: TLR2's share price has been volatile over the past 3 months compared to the Austrian market.
Volatility Over Time: TLR2's weekly volatility has decreased from 17% to 9% over the past year, but is still higher than 75% of Austrian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 2,842 | Irwin Simon | www.tilray.com |
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products.
Tilray Brands, Inc. Fundamentals Summary
| TLR2 fundamental statistics | |
|---|---|
| Market cap | €481.10m |
| Earnings (TTM) | -€1.18b |
| Revenue (TTM) | €754.17m |
Is TLR2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TLR2 income statement (TTM) | |
|---|---|
| Revenue | US$858.28m |
| Cost of Revenue | US$620.72m |
| Gross Profit | US$237.55m |
| Other Expenses | US$1.58b |
| Earnings | -US$1.34b |
Last Reported Earnings
Feb 28, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -11.27 |
| Gross Margin | 27.68% |
| Net Profit Margin | -156.67% |
| Debt/Equity Ratio | 16.4% |
How did TLR2 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/23 02:12 |
| End of Day Share Price | 2026/06/23 00:00 |
| Earnings | 2026/02/28 |
| Annual Earnings | 2025/05/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Tilray Brands, Inc. is covered by 27 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Aaron Grey | Alliance Global Partners |
| Frederico Yokota Choucair Gomes | ATB Cormark |
| Jesse Pytlak | ATB Cormark Historical (Cormark Securities) |